CIACCO-2024 (11th Annual symposium on Cytokines in Inflammation, Ageing, CanCer and Obesity)
CIACCO-2024(第11届炎症、衰老、癌症和肥胖中细胞因子年度研讨会)
基本信息
- 批准号:487821
- 负责人:
- 金额:$ 0.73万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Miscellaneous Programs
- 财政年份:2023
- 资助国家:加拿大
- 起止时间:2023-07-01 至 2024-07-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Cytokines are a diverse group of molecules that serve as a language for cells to communicate among each other. They play essential roles in the development and well being of the human body, as well as in tissue repair after injury. In fact, lack of certai
细胞因子是一组不同的分子,它们作为细胞相互交流的语言。它们在人体的发育和健康以及损伤后的组织修复中起着至关重要的作用。事实上,缺乏一定的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rafei Moutih其他文献
Rafei Moutih的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rafei Moutih', 18)}}的其他基金
Immunoproteasome-expressing mesenchymal stromal cells: a new tool for cancer vaccination
表达免疫蛋白酶体的间充质基质细胞:癌症疫苗接种的新工具
- 批准号:
468068 - 财政年份:2022
- 资助金额:
$ 0.73万 - 项目类别:
Operating Grants
The impact of mTOR and p53 signaling pathways on the MHCI immunopeptidome of cancer cells
mTOR和p53信号通路对癌细胞MHCI免疫肽组的影响
- 批准号:
179040 - 财政年份:2009
- 资助金额:
$ 0.73万 - 项目类别:
Fellowship Programs
相似海外基金
Basic research for macrophage immune check point inhibition as a novel esophageal cancer therapy
巨噬细胞免疫检查点抑制作为食管癌新型疗法的基础研究
- 批准号:
23K15525 - 财政年份:2023
- 资助金额:
$ 0.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Research Specialist in Cancer Genomics to Integrate Basic Research and Clinical Data
癌症基因组学研究专家,整合基础研究和临床数据
- 批准号:
10733649 - 财政年份:2023
- 资助金额:
$ 0.73万 - 项目类别:
Basic research to provide standard treatment for people with disabilities with cancer treatment disparities.
为癌症治疗差异的残疾人提供标准治疗的基础研究。
- 批准号:
21K17249 - 财政年份:2021
- 资助金额:
$ 0.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Basic research on drugs that can dramatically improve the effectiveness of BNCT in multifaceted cancer control
可显着提高BNCT在多方面癌症控制中的有效性的药物基础研究
- 批准号:
21K19449 - 财政年份:2021
- 资助金额:
$ 0.73万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Basic research for trans-differentiation using 3D culture in gastro-intentional cancer
利用 3D 培养进行胃癌转分化的基础研究
- 批准号:
21K08783 - 财政年份:2021
- 资助金额:
$ 0.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic research on the development of new therapeutic methods for cancer metastasis targeting the CDCP1 extracellular domain
针对CDCP1胞外结构域开发癌症转移新治疗方法的基础研究
- 批准号:
21K07165 - 财政年份:2021
- 资助金额:
$ 0.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic research on personalized iPSDCs cancer vaccine therapy targeting neoantigen from patients
针对患者新抗原的个性化 iPSDC 癌症疫苗治疗的基础研究
- 批准号:
20K17628 - 财政年份:2020
- 资助金额:
$ 0.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Basic research for development of new treatment for cachexia by gastric cancer focusing on protein farnesylation
以蛋白质法尼基化为重点开发胃癌恶病质新疗法的基础研究
- 批准号:
20K09037 - 财政年份:2020
- 资助金额:
$ 0.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic research for the development of novel anticancer drugs targeting senescent cells induced by cancer treatment
针对癌症治疗诱导的衰老细胞开发新型抗癌药物的基础研究
- 批准号:
20K07591 - 财政年份:2020
- 资助金额:
$ 0.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the novel indole compound to suppress colitis-associated colorectal cancer and basic research for clinical application
发现抑制结肠炎相关结直肠癌的新型吲哚化合物及其临床应用基础研究
- 批准号:
20K09026 - 财政年份:2020
- 资助金额:
$ 0.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)